ロード中...
Biosimilars: Considerations for Payers
Evaluating biosimilars requires payers to go beyond cost considerations: safety and efficacy, reliability of supply and logistics, and the impact of state laws on substitution and interchangeability must all be deliberated.
保存先:
| 出版年: | P T |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MediMedia USA, Inc.
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6355057/ https://ncbi.nlm.nih.gov/pubmed/30766011 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|